- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01085799
Education Intervention to Reduce Helminth Infections and Absenteeism in Grade 5 School-children
March 15, 2011 updated by: McGill University Health Centre/Research Institute of the McGill University Health Centre
Effectiveness of a Post-deworming Education Intervention to Reduce Soil-transmitted Helminth Infections and Absenteeism in Grade 5 School-children in a Community of Extreme Poverty, Peruvian Amazon
To efficiently control soil-transmitted helminths (Ascaris, Trichuris, and hookworm), WHO, PAHO, and others recommend the inclusion of an education strategy in school-based deworming programs.
However, the effectiveness of such a strategy on the rate of STH re-infection and on education indicators, such as absenteeism, remains to be fully understood.
The proposed research aims to evaluate the effectiveness of a post-deworming education intervention targeted to Grade 5 school children enrolled in Belén's schools using a cluster-randomized trial design.
Results will be used to inform school-based deworming programs in Peru and other similar endemic areas in Latin America and, indeed, around the world.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
1101
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Loreto
-
Iquitos, Loreto, Peru
- Asociación Civil Selva Amazónica
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Girls and boys enrolled in Grade 5 in eligible schools located in the Belén district of Iquitos, Peru. Eligible schools have a minimum of 10 boys and 10 girls enrolled in grade 5.
- Informed written consent obtained from the parents or legal guardian of the child.
- Verbal assent from child.
Exclusion Criteria:
- Parents (or guardians) refusing participation of their child.
- Child who refuses to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Health Education Intervention
Groups of schools receiving the health education intervention
|
This is a health hygiene education strategy which encourages the pro-active role of both teachers and students and changes in attitudes and practices with the aim of keeping the level of parasite infection low, through increased knowledge.
|
|
No Intervention: Control Schools - Regular curriculum
Groups of schools not receiving the health education intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Soil-transmitted helminth re-infection (Ascaris, Trichuris, or Hookworm).
Time Frame: 4 months post-deworming
|
4 months post-deworming
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Absenteeism rate.
Time Frame: During the first 4 months following deworming
|
During the first 4 months following deworming
|
|
Eggs per grams reduction rate.
Time Frame: 4 months post-deworming
|
4 months post-deworming
|
|
Weight gain (kg)
Time Frame: 4 months post-deworming
|
4 months post-deworming
|
|
Height gain (cm)
Time Frame: 4 months post-deworming
|
4 months post-deworming
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Theresa W. Gyorkos, PhD, McGill University Health Centre/Research Institute of the McGill University Health Centre
- Study Director: Martín Casapía, MD, MPH, Asociación Civil Selva Amazónica
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
October 1, 2010
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
March 10, 2010
First Submitted That Met QC Criteria
March 11, 2010
First Posted (Estimate)
March 12, 2010
Study Record Updates
Last Update Posted (Estimate)
March 16, 2011
Last Update Submitted That Met QC Criteria
March 15, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GEN-09-214
- HOA-80064 (Other Grant/Funding Number: Canadian Institutes of Health Research)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infections
-
Han TongyanCompletedLower Respiratory Tract Infections | RSV InfectionsChina
-
University Hospital, Strasbourg, FranceRecruiting
-
Ab&B Bio-tech Co., Ltd.JSYither Biotech Co., LtdRecruitingRespiratory Syncytial Virus InfectionsChina
-
GlaxoSmithKlineRecruiting
-
ShionogiRecruitingRespiratory Syncytial Virus InfectionsUnited States, Bulgaria, South Africa, Poland, Japan
-
First Affiliated Hospital of Ningbo UniversityRecruiting
-
Dilla UniversityNot yet recruiting
-
Emergent BioSolutionsDepartment of Health and Human Services; Centers for Disease Control and PreventionNot yet recruitingInfections, Bacterial
-
PfizerNot yet recruitingRespiratory Syncytial Virus Infections
-
Chinese University of Hong KongRecruitingTuberculosisHong Kong
Clinical Trials on Health Education Intervention
-
Federal University of PelotasRecruitingBreast Cancer FemaleBrazil
-
University of MonastirCompletedHealth Education, COVID-19, Quarantine, Anxiety, PandemicTunisia
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Lihua XuCompletedCardiovascular DiseasesChina
-
Columbia UniversityJohns Hopkins University; University of South Florida; University of Pittsburgh; National Institute on Aging (NIA) and other collaboratorsRecruitingCognitive Impairment | Alzheimer Disease | Hearing LossUnited States
-
Hiroshima UniversityCompleted
-
Peking UniversityActive, not recruitingPelvic Floor DysfunctionChina
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
Kaiser PermanenteUniversity of California, San FranciscoCompletedDementia | Alzheimer DiseaseUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada